{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:56:49Z","timestamp":1782755809659,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajkd.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1053\/j.ajkd.2023.09.018","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T20:20:57Z","timestamp":1700511657000},"page":"615-623.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT"],"prefix":"10.1053","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3465-4208","authenticated-orcid":false,"given":"Simon B.","family":"Ascher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarett D.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"de Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav S.","family":"Garimella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein I.","family":"Hallan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Wettersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasantha K.","family":"Jotwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Killeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H.","family":"Ix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1053\/j.ajkd.2023.09.018_bib1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2023.09.018_bib2","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1681\/ASN.2018121261","article-title":"Implications of early decline in eGFR due to intensive BP control for cardiovascular outcomes in SPRINT","volume":"30","author":"Beddhu","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.09.018_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2018.07.015","article-title":"Effects of intensive blood pressure lowering on kidney tubule injury in CKD: a longitudinal subgroup analysis in SPRINT","volume":"73","author":"Malhotra","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2023.09.018_bib4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/M18-1037","article-title":"Kidney damage biomarkers and incident chronic kidney disease during blood pressure reduction: a case-control study","volume":"169","author":"Zhang","year":"2018","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2023.09.018_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.7326\/M16-2966","article-title":"Effects of intensive systolic blood pressure control on kidney and cardiovascular outcomes in persons without kidney disease","volume":"167","author":"Beddhu","year":"2017","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1053\/j.ajkd.2023.09.018_bib6","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1681\/ASN.2017020148","article-title":"Effects of intensive BP control in CKD","volume":"28","author":"Cheung","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2023.09.018_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1053\/j.ajkd.2023.09.018_bib8","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.109.884866","article-title":"B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies","volume":"120","author":"Di Angelantonio","year":"2009","journal-title":"Circulation"},{"issue":"10","key":"10.1053\/j.ajkd.2023.09.018_bib9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S2213-8587(16)30196-6","article-title":"Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis","volume":"4","author":"Willeit","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1053\/j.ajkd.2023.09.018_bib10","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1373\/clinchem.2013.205716","article-title":"Biomarkers of cardiovascular stress and incident chronic kidney disease","volume":"59","author":"Ho","year":"2013","journal-title":"Clin Chem"},{"issue":"6","key":"10.1053\/j.ajkd.2023.09.018_bib11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ahj.2014.09.008","article-title":"Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study","volume":"168","author":"Park","year":"2014","journal-title":"Am Heart J"},{"key":"10.1053\/j.ajkd.2023.09.018_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12882-015-0163-9","article-title":"Plasma levels of natriuretic peptides and development of chronic kidney disease","volume":"16","author":"Ogawa","year":"2015","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2023.09.018_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2215\/CJN.04910514","article-title":"NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults","volume":"10","author":"Bansal","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2023.09.018_bib14","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s00125-017-4297-0","article-title":"Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes","volume":"60","author":"Jenks","year":"2017","journal-title":"Diabetologia"},{"issue":"4","key":"10.1053\/j.ajkd.2023.09.018_bib15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ekir.2021.01.006","article-title":"N-terminal pro-B-type natriuretic peptide and incident CKD","volume":"6","author":"Sasaki","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"7","key":"10.1053\/j.ajkd.2023.09.018_bib16","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1373\/clinchem.2006.083170","article-title":"B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study","volume":"53","author":"Spanaus","year":"2007","journal-title":"Clin Chem"},{"issue":"5","key":"10.1053\/j.ajkd.2023.09.018_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1053\/j.ajkd.2011.05.020","article-title":"Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD","volume":"58","author":"Desai","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.ajkd.2023.09.018_bib18","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1093\/ndt\/gfs365","article-title":"Plasma B-type natriuretic peptide level predicts kidney prognosis in patients with predialysis chronic kidney disease","volume":"27","author":"Yasuda","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2023.09.018_bib19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/j.ajkd.2014.08.021","article-title":"Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study","volume":"65","author":"Kim","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2023.09.018_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/HJH.0000000000000847","article-title":"Plasma B-type natriuretic peptide concentration is independently associated with kidney function decline in Japanese patients with chronic kidney disease","volume":"34","author":"Yoshitomi","year":"2016","journal-title":"J\u00a0Hypertens"},{"issue":"11","key":"10.1053\/j.ajkd.2023.09.018_bib21","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1373\/clinchem.2019.305797","article-title":"Cardiac and stress biomarkers and chronic kidney disease progression: the CRIC Study","volume":"65","author":"Bansal","year":"2019","journal-title":"Clin Chem"},{"issue":"1","key":"10.1053\/j.ajkd.2023.09.018_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ajkd.2020.07.011","article-title":"Novel risk factors for progression of diabetic and nondiabetic CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"77","author":"Anderson","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2023.09.018_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159914","article-title":"Clinical value of natriuretic peptides in predicting time to dialysis in stage 4 and 5 chronic kidney disease patients","volume":"11","author":"Sundqvist","year":"2016","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1053\/j.ajkd.2023.09.018_bib24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2174\/1871530318666180426112050","article-title":"Serum N-terminal pro-brain natriuretic peptide level is associated with the development of chronic kidney diseases in patients with type 2 diabetes","volume":"18","author":"Sawada","year":"2018","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"10.1053\/j.ajkd.2023.09.018_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1253\/circrep.CR-19-0044","article-title":"N-terminal pro-B-type natriuretic peptide is a predictor of chronic kidney disease in an Asian general population \u2013 the Ohasama Study","volume":"2","author":"Nakayama","year":"2019","journal-title":"Circ Rep"},{"issue":"5","key":"10.1053\/j.ajkd.2023.09.018_bib26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials"},{"issue":"12","key":"10.1053\/j.ajkd.2023.09.018_bib27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jamacardio.2021.3187","article-title":"Associations of high-sensitivity troponin and natriuretic peptide levels with outcomes after intensive blood pressure lowering: findings from the SPRINT randomized clinical trial","volume":"6","author":"Berry","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.09.018_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/CIRCULATIONAHA.122.059960","article-title":"Effect of intensive blood pressure control on troponin and natriuretic peptide levels: findings from SPRINT","volume":"147","author":"Berry","year":"2023","journal-title":"Circulation"},{"issue":"19","key":"10.1053\/j.ajkd.2023.09.018_bib29","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1053\/j.ajkd.2023.09.018_bib30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/HYPERTENSIONAHA.117.10479","article-title":"Blood pressure measurement in SPRINT (Systolic Blood Pressure Intervention Trial)","volume":"71","author":"Johnson Karen","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"10.1053\/j.ajkd.2023.09.018_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J\u00a0R Stat Soc Ser B Methodol"},{"issue":"9","key":"10.1053\/j.ajkd.2023.09.018_bib32","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","article-title":"Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction","volume":"9","author":"Damman","year":"2007","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1053\/j.ajkd.2023.09.018_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1053\/j.ajkd.2023.09.018_bib34","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623009332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623009332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T20:28:20Z","timestamp":1729110500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638623009332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0272638623009332"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.09.018","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}